Case Reports
doi: 10.1183/13993003.00118-2019.
Print 2019 Jul.
Failure with acquired resistance of an optimised bedaquiline-based treatment regimen for pulmonary分枝杆菌复杂疾病
从属关系
- PMID：31000671
- DOI:10.1183/13993003.00118-2019
剪贴板中的项目
Case Reports
Failure with acquired resistance of an optimised bedaquiline-based treatment regimen for pulmonary分枝杆菌复杂疾病
EUR RESSIR j.
.
免费文章
不抽象的available
利益冲突声明
利益冲突：S.M.H.Zweijpfenning没有什么可披露的。利益冲突：J.A。Schildkraut没有什么可披露的。利益冲突：J.P.M.冷却没有什么可披露的。利益冲突：C。Ruesen没有什么可披露的。利益冲突：E。Koenraad无话可说。利益冲突：A。Janssen没有什么可披露的。利益冲突：M.M. Ruth has nothing to disclose. Conflict of interest: A.S. de Jong has nothing to disclose. Conflict of interest: S. Kuipers has nothing to disclose. Conflict of interest: R.E. Aarnoutse has nothing to disclose. Conflict of interest: C. Magis-Escurra has nothing to disclose. Conflict of interest: W. Hoefsloot has nothing to disclose. Conflict of interest: J. van Ingen reports grants from Netherlands Organization for Scientific Research (NWO/ZonMW grant Veni 016.176.024), during the conduct of the study.
Comment in
-
Improving outcomes in patients with non-tuberculous mycobacterial disease: is there light at the end of the tunnel?EUR RESSIR j. 2019 Jul 11;54(1):1901149. doi: 10.1183/13993003.01149-2019. Print 2019 Jul. Eur Respir J. 2019。 PMID：31296786 不抽象的available.
Similar articles
-
Bedaquiline as a potential agent in the treatment ofM.胞内和M. Aviuminfections.Eur Respir J. 2017 3月22日； 49（3）：1601969。doi：10.1183/13993003.01969-2016。印刷2017年3月。 Eur Respir J. 2017。 PMID：28331039 不抽象的available.
-
In vitroactivity of bedaquiline against分枝杆菌复杂的。J Med Microbiol. 2021 Oct;70(10). doi: 10.1099/jmm.0.001439. J Med Microbiol. 2021. PMID：34668850
-
无结核分枝杆菌肺部疾病患者的Bedaquiline作为挽救疗法的初步结果。胸部。2015 Aug;148(2):499-506. doi: 10.1378/chest.14-2764. 胸部。2015。 PMID：25675393 Free PMC article.
-
在利福平治疗中，IgA肾病患者需要调整泼尼松龙的泼尼松龙治疗分枝杆菌复合物肺部疾病吗？毒品监测。2019 Aug;41(4):546-547. doi: 10.1097/FTD.0000000000000647. 毒品监测。2019。 PMID：31033860 不抽象的available.
-
[Treatment of mycobacterial avium complex pulmonary disease].Zhonghua Jie He He Hu Xi Za Zhi. 2020 Dec 12;43(12):1112-1116. doi: 10.3760/cma.j.cn112147-20200922-00998. Zhonghua Jie He He Hu Xi Za Zhi. 2020. PMID：33333649 审查。 中国人。
被引用3articles
-
Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report.BMC感染。2020年5月24日； 20（1）：365。doi：10.1186/s12879-020-05075-7。 BMC感染。2020. PMID：32448204 Free PMC article.
-
Bedaquiline，单独或与丙咪成结合的疗效，对C3HEB/FEJ小鼠中的分枝杆菌。Antimicrob Agents Chemother. 2020 May 21;64(6):e00114-20. doi: 10.1128/AAC.00114-20. Print 2020 May 21. Antimicrob Agents Chemother. 2020. PMID：32253217 Free PMC article.
-
Recent advances in nontuberculous mycobacterial lung infections.f1000res。2019 Oct 1;8:F1000 Faculty Rev-1710. doi: 10.12688/f1000research.20096.1. eCollection 2019. f1000res。2019。 PMID：31602293 Free PMC article. 审查。
出版类型
-
Actions
-
Actions
-
Actions
MeSH terms
-
Actions
-
Actions
-
Actions
-
Actions
-
Actions
-
Actions
-
Actions
-
Actions
-
Actions
-
Actions
-
Actions
Substances
-
Actions
-
Actions
-
Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
医疗的
